In clinical studies, MIEBO
was shown to:
Significantly reduce
signs of dry eye*
With continued use of MIEBO, doctors saw improvements in the damage on the surface of the eye.
*MIEBO was studied against saline in 2 clinical trials of more than 1200 patients who were treated 4 times per day.
In clinical studies, MIEBO
was shown to:
Significantly reduce
symptoms of dry eye*
People in the studies felt their eye dryness significantly improved.
*MIEBO was studied against saline in 2 clinical trials of more than 1200 patients who were treated 4 times per day.
Relief in as little as 2 weeks
In the studies, doctors checked the signs and symptoms of dry eye after 2 weeks, and again after 8 weeks. Patients saw significant improvement at both checkpoints while they were continuing to use MIEBO.
Side effects with MIEBO are uncommon
MIEBO is a prescription eye drop approved by the FDA. Because it’s a prescription, it was studied in-depth in patients, unlike over-the-counter artificial tears.
The safety of MIEBO was studied in more than 600 people in 2 clinical trials that lasted 57 days (GOBI and MOJAVE). No serious side effects were seen in either study. The data below is an average of the studies.
Serious side effects
No one treated with MIEBO experienced serious side effects.
felt burning or stinging
Very few people reported burning or stinging when putting in MIEBO (GOBI: 3 people; MOJAVE: 0 people).
stopped using MIEBO due to side effects
Of the 614 people studied, only 1 person stopped using MIEBO because of side effects (GOBI: 1 person; MOJAVE: 0 people).
reported blurred vision
The most common side effect seen with MIEBO was blurred vision, which occurred in 2.1% of people. It usually resolved within minutes (GOBI: 9 people; MOJAVE: 4 people). 0.8% of people also experienced eye redness.
How MIEBO works
MIEBO works differently
See how MIEBO protects against too much tear evaporation.
INDICATION
MIEBO® (perfluorohexyloctane ophthalmic solution) is used to treat the signs and symptoms of dry eye disease.
IMPORTANT SAFETY INFORMATION
- Remove contact lenses before using MIEBO and wait for at least 30 minutes before reinserting
- It is important to use MIEBO exactly as prescribed
- It is not known if MIEBO is safe and effective in children under the age of 18
- The most common eye side effect seen in studies was blurred vision (1% to 3% of patients reported blurred vision and eye redness)
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.
Click here for full Prescribing Information for MIEBO.
INDICATION
MIEBO® (perfluorohexyloctane ophthalmic solution) is used to treat the signs and symptoms of dry eye disease.
IMPORTANT SAFETY INFORMATION
- Remove contact lenses before using MIEBO and wait for at least 30 minutes before reinserting
- It is important to use MIEBO exactly as prescribed
- It is not known if MIEBO is safe and effective in children under the age of 18
- The most common eye side effect seen in studies was blurred vision (1% to 3% of patients reported blurred vision and eye redness)
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.
Click here for full Prescribing Information for MIEBO.
